115 related articles for article (PubMed ID: 7554042)
1. The activity of deoxyspergualin in multidrug-resistant cells.
Holmes JA; Twentyman PR
Cancer Chemother Pharmacol; 1995; 36(6):499-505. PubMed ID: 7554042
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
[TBL] [Abstract][Full Text] [Related]
3. Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistance.
Coley HM; Twentyman PR; Workman P
Anticancer Drug Des; 1992 Dec; 7(6):471-81. PubMed ID: 1337431
[TBL] [Abstract][Full Text] [Related]
4. Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines.
Robson C; Wright KA; Twentyman PR; Lambert PA; Griffin RJ
Biochem Pharmacol; 1998 Oct; 56(7):807-16. PubMed ID: 9774142
[TBL] [Abstract][Full Text] [Related]
5. Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.
Coley HM; Twentyman PR; Workman P
Biochem Pharmacol; 1989 Dec; 38(24):4467-75. PubMed ID: 2604747
[TBL] [Abstract][Full Text] [Related]
6. Serum effect on cellular uptake of spermidine, spergualin, 15-deoxyspergualin, and their metabolites by L5178Y cells.
Kunimoto S; Nosaka C; Xu CZ; Takeuchi T
J Antibiot (Tokyo); 1989 Jan; 42(1):116-22. PubMed ID: 2921216
[TBL] [Abstract][Full Text] [Related]
7. The efflux of anthracyclines in multidrug-resistant cell lines.
Coley HM; Twentyman PR; Workman P
Biochem Pharmacol; 1993 Oct; 46(8):1317-26. PubMed ID: 7902089
[TBL] [Abstract][Full Text] [Related]
8. Effect of 15-deoxyspergualin, a microbial angiogenesis inhibitor, on the biological activities of bovine vascular endothelial cells.
Oikawa T; Hasegawa M; Morita I; Murota S; Ashino H; Shimamura M; Kiue A; Hamanaka R; Kuwano M; Ishizuka M
Anticancer Drugs; 1992 Jun; 3(3):293-9. PubMed ID: 1381973
[TBL] [Abstract][Full Text] [Related]
9. Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitro.
Twentyman PR; Wright KA; Wallace HM
Br J Cancer; 1992 Mar; 65(3):335-40. PubMed ID: 1313690
[TBL] [Abstract][Full Text] [Related]
10. Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.
Dale IL; Tuffley W; Callaghan R; Holmes JA; Martin K; Luscombe M; Mistry P; Ryder H; Stewart AJ; Charlton P; Twentyman PR; Bevan P
Br J Cancer; 1998 Oct; 78(7):885-92. PubMed ID: 9764579
[TBL] [Abstract][Full Text] [Related]
11. Kinetic studies of the interaction between spergualin or 15-deoxyspergualin and amine oxidase from bovine plasma.
Kunimoto S; Takeuchi T
J Antibiot (Tokyo); 1994 Oct; 47(10):1130-5. PubMed ID: 7961163
[TBL] [Abstract][Full Text] [Related]
12. Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo.
Harrison SD; Brockman RW; Trader MW; Laster WR; Griswold DP
Invest New Drugs; 1987 Dec; 5(4):345-51. PubMed ID: 3436739
[TBL] [Abstract][Full Text] [Related]
13. 15-Deoxyspergualin, an antiproliferative agent for human and mouse leukemia cells shows inhibitory effects on the synthetic pathway of polyamines.
Hibasami H; Tsukada T; Suzuki R; Takano K; Takaji S; Takeuchi T; Shirakawa S; Murata T; Nakashima K
Anticancer Res; 1991; 11(1):325-30. PubMed ID: 2018367
[TBL] [Abstract][Full Text] [Related]
14. Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A.
Coley HM; Twentyman PR; Workman P
Cancer Chemother Pharmacol; 1989; 24(5):284-90. PubMed ID: 2547527
[TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance by tacrolimus hydrate.
Wu J; Furusawa S; Nakano S; Takahashi M; Chiba H; Takayanagi M; Takayanagi Y; Sasaki K
Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):651-8. PubMed ID: 9121220
[TBL] [Abstract][Full Text] [Related]
16. The antiproliferative action of deoxyspergualin is different from that induced by amine oxidase.
Kuramochi H; Hiratsuka M; Nagamine S; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1988 Feb; 41(2):234-8. PubMed ID: 3356611
[TBL] [Abstract][Full Text] [Related]
17. Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine.
Gosland MP; Gillespie MN; Tsuboi CP; Tofiq S; Olson JW; Crooks PA; Aziz SM
Cancer Chemother Pharmacol; 1996; 37(6):593-600. PubMed ID: 8612315
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cell growth through inactivation of eukaryotic translation initiation factor 5A (eIF5A) by deoxyspergualin.
Nishimura K; Ohki Y; Fukuchi-Shimogori T; Sakata K; Saiga K; Beppu T; Shirahata A; Kashiwagi K; Igarashi K
Biochem J; 2002 May; 363(Pt 3):761-8. PubMed ID: 11964177
[TBL] [Abstract][Full Text] [Related]
19. Polyamine cytotoxicity in the presence of bovine serum amine oxidase.
Sharmin S; Sakata K; Kashiwagi K; Ueda S; Iwasaki S; Shirahata A; Igarashi K
Biochem Biophys Res Commun; 2001 Mar; 282(1):228-35. PubMed ID: 11263996
[TBL] [Abstract][Full Text] [Related]
20. Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine.
Porter CW; Ganis B; Rustum Y; Wrzosek C; Kramer DL; Bergeron RJ
Cancer Res; 1994 Nov; 54(22):5917-24. PubMed ID: 7954423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
